Medtronic Neuromodulation Medtronic Sutureless Pump Connector Revision Kit, model 8578. Contents: Catheter interface with attached sutureless pump connector, catheter, connector pin, and strain-relief sleeve, Strain-relief Sleeves (2). Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Medtronic Sutureless Pump Connector Revision Kit, model 8578. Contents: Catheter interface with attached sutureless pump connector, catheter, connector pin, and strain-relief sleeve, Strain-relief Sleeves (2).
Brand
Medtronic Neuromodulation
Lot Codes / Batch Numbers
All SC Catheter Revision Kits
Products Sold
All SC Catheter Revision Kits
Medtronic Neuromodulation is recalling Medtronic Sutureless Pump Connector Revision Kit, model 8578. Contents: Catheter interface with at due to Disconnection of the Medtronic sutureless connector (SC) catheters from the catheter port on the pump, or occlusion between the sutureless pump connec. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Disconnection of the Medtronic sutureless connector (SC) catheters from the catheter port on the pump, or occlusion between the sutureless pump connector and the catheter port on the pump.
Recommended Action
Per FDA guidance
Medtronic sent A Safety Alert dated June 2008, on June 27, 2008, to healthcare professionals, which described the issues of occlusion and disconnect. The letter identifies the affected catheter and revision kit model numbers and the associated implantable infusion pumps. The issues do not involve Medtronic MiniMed insulin pump. The letter refers the HCP to recommendations for Implant Techniques and Recommendations for Patency Verification that are included with the letter. The letter also includes recommendations for managing patients with implanted SC catheters.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
PR
Page updated: Jan 10, 2026